FDA Inspection 695053 — RMA Long Island IVF

RMA Long Island IVF — FEI 3007067646

The FDA completed an inspection of RMA Long Island IVF on Oct 20, 2010 in Melville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 20, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Melville, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible